The SEARCH Collaborative Group, “SLCO1B1 Variants and Statin-Induced Myopa-thy—A Genomewide Study,” The New England Journal of Medicine, Vol. 359, No. 8, 2008, pp. 789-799.
has been cited by the following article:
TITLE: The Pharmacogenomic Consideration of Lipid Homeostasis: Role of Pharmacist in Ethical and Economic Consideration
AUTHORS: Paul Serafin, Mohammad Newaz
KEYWORDS: Pharmacogenomics; Lipid; Atherosclerosis; CVD; Pharmacogenetic Testing
JOURNAL NAME: Pharmacology & Pharmacy, Vol.4 No.1, January 30, 2013
ABSTRACT: Usage of lipid lowering drugs is a common therapeutic steps in preventing or treating diseases. With the advent of Pharmacogenetics and Pharmacogenomics, it is now important to understand the implication of pharmacogenetic testing in patient care. Ethical and economic concerns are wide considered to be an issue in a pharmacy setting and it is important that the health care professionals in the pharmacy setting need to be aware. This article encompasses current pharmacogenomic information that is relevant to lipid homeostasis and addressed the concerns of patient that may be a factor in ultimate decision making process.